Literature DB >> 22740418

Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.

Sanda Remakus1, Daniel Rubio, Xueying Ma, Alessandro Sette, Luis J Sigal.   

Abstract

The antigens recognized by individual CD8(+) T cells are small peptides bound to major histocompatibility complex (MHC) class I molecules. The CD8(+) T cell response to a virus is restricted to several peptides, and the magnitudes of the effector as well as memory phases of the response to the individual peptides are generally hierarchical. The peptide eliciting a stronger response is called immunodominant (ID), and those with smaller-magnitude responses are termed subdominant (SD). The relative importance of ID and SD determinants in protective immunity remains to be fully elucidated. We previously showed that multispecific memory CD8(+) T cells can protect susceptible mice from mousepox, an acute lethal viral disease. It remained unknown, however, whether CD8(+) T cells specific for single ID or SD peptides could be protective. Here, we demonstrate that immunization with dendritic cells pulsed with ID and some but not all SD peptides induces memory CD8(+) T cells that are fully capable of protecting susceptible mice from mousepox. Additionally, while natural killer (NK) cells are essential for the natural resistance of nonimmune C57BL/6 (B6) to mousepox, we show that memory CD8(+) T cells of single specificity also protect B6 mice depleted of NK cells. This suggests it is feasible to produce effective antiviral CD8(+) T cell vaccines using single CD8(+) T cell determinants and that NK cells are no longer essential when memory CD8(+) T cells are present.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740418      PMCID: PMC3446599          DOI: 10.1128/JVI.00981-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

Review 1.  The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.

Authors:  Judy Lieberman
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

2.  MHC class Ia-restricted memory T cells inhibit expansion of a nonprotective MHC class Ib (H2-M3)-restricted memory response.

Authors:  Sara E Hamilton; Brandon B Porter; Kelly A Nordyke Messingham; Vladimir P Badovinac; John T Harty
Journal:  Nat Immunol       Date:  2004-01-25       Impact factor: 25.606

Review 3.  Natural killer cells and viral infections.

Authors:  Anthony R French; Wayne M Yokoyama
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

4.  Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors.

Authors:  Qing Ge; Ailin Bai; Brendan Jones; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

Review 5.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Vaccinia pneumonia in mice. A light and electron microscopic and viral assay study.

Authors:  M Montasir; E R Rabin; C A Phillips
Journal:  Am J Pathol       Date:  1966-05       Impact factor: 4.307

7.  Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load.

Authors:  Erin E West; Ben Youngblood; Wendy G Tan; Hyun-Tak Jin; Koichi Araki; Gabriela Alexe; Bogumila T Konieczny; Silvia Calpe; Gordon J Freeman; Cox Terhorst; W Nicholas Haining; Rafi Ahmed
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

8.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality.

Authors:  G D Wallace; R M Buller; H C Morse
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells.

Authors:  Petra Wolint; Michael R Betts; Richard A Koup; Annette Oxenius
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  21 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

Review 2.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

3.  Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Authors:  Pavlo Gilchuk; Charles T Spencer; Stephanie B Conant; Timothy Hill; Jennifer J Gray; Xinnan Niu; Mu Zheng; John J Erickson; Kelli L Boyd; K Jill McAfee; Carla Oseroff; Sine R Hadrup; Jack R Bennink; William Hildebrand; Kathryn M Edwards; James E Crowe; John V Williams; Søren Buus; Alessandro Sette; Ton N M Schumacher; Andrew J Link; Sebastian Joyce
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

Review 4.  Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.

Authors:  Arif Azam Khan; Ruchi Srivastava; Patricia Prado Lopes; Christine Wang; Thanh T Pham; Justin Cochrane; Nhi Thi Uyen Thai; Lucas Gutierrez; Lbachir Benmohamed
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

5.  Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.

Authors:  Pedro Alves-Peixoto; Maria Férez; Cory J Knudson; Colby Stotesbury; Carolina R Melo-Silva; Eric B Wong; Margarida Correia-Neves; Luis J Sigal
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

6.  CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.

Authors:  Min Fang; Sanda Remakus; Felicia Roscoe; Xueying Ma; Luis J Sigal
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

7.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.

Authors:  Andrew L Ferguson; Jaclyn K Mann; Saleha Omarjee; Thumbi Ndung'u; Bruce D Walker; Arup K Chakraborty
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

8.  Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection.

Authors:  Sanda Remakus; Daniel Rubio; Avital Lev; Xueying Ma; Min Fang; Ren-Huan Xu; Luis J Sigal
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

9.  Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.

Authors:  Xavier Dervillez; Huma Qureshi; Aziz A Chentoufi; Arif A Khan; Elizabeth Kritzer; David C Yu; Oscar R Diaz; Chetan Gottimukkala; Mina Kalantari; Maria C Villacres; Vanessa M Scarfone; Denise M McKinney; John Sidney; Alessandro Sette; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Immunol       Date:  2013-10-07       Impact factor: 5.422

10.  Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells.

Authors:  Alan M Watson; Lawrence M Mylin; Megan M Thompson; Todd D Schell
Journal:  J Immunol       Date:  2012-11-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.